Risk-assessment models are important for the identification of individuals at high risk of developing cardiovascular diseases. Although several well-known models for risk assessment have been published in Europe and the USA, very few studies have discussed the development of risk-assessment models from a global perspective. In this Review, Zhao and colleagues discuss differences in risk-assessment recommendations from developed compared with developing countries, and consider their effects on clinical practice.
